Amrit Kaur Kaler: The Hidden Genetic Drivers of Thrombosis
Amrit Kaur Kaler, Consultant in the Department of Genetics and Molecular Medicine at Kokilaben Dhirubhai Ambani Hospital, shared a post on LinkedIn about a recent article she and his colleagues co-authored, published in Journal of Thrombosis and Haemostasis, adding:
”Thrombophilia genetic polymorphisms are inherited variations in genes controlling blood coagulation, increasing the risk of venous and arterial thrombosis.
Common polymorphisms include Factor V Leiden (FVL 1691GA), Prothrombin (FII 20210GA), and MTHFR variants, which enhance clot formation or inhibit fibrinolysis. These genetic factors can cause hypercoagulable states, leading to VTE or reproductive issues.
Thanks to Dr R Sekhar, our vascular surgeon for sharing deep insights into the management of thrombosis. Thanks to Sameer Tulpule and all the authors for their contribution.”
Title: Re-evaluation of thrombophilia testing in clinical practice: Insights from an Indian cohort
Authors: Amrit Kaur Kaler, Sameer Tulpule, Gaurav Mehta, Tushar Premraj Raut, Dattatray Solanke, Raghuram Sekhar, Vatsal Kothari, Subhash Aga

Stay updated on all scientific advances with Hemostasis Today.
-
Aug 13, 2026, 18:39Lukas Röthlisberger: Real-World Evidence on Effectiveness and Safety of Rivaroxaban in Children
-
Aug 13, 2026, 18:36Soner Yilmaz: Blood Safety in Türkiye Through More Than 22.5 Million Blood Donations
-
Aug 13, 2026, 18:31Muthukumarasamy Raja: FDA Approval of EZPLAZ Marks a Breakthrough in Emergency Plasma Care
-
Aug 13, 2026, 18:29Peter Zdziarski: Protecting Our Community While Creating a Future Where We Are No Longer Needed
-
Aug 13, 2026, 18:29Morgan E Amos: Thrilled to Receive the Student Research Award From HTRS
-
Aug 13, 2026, 16:38Sheharyar Raza: Plasma Exchange in Multiple Sclerosis
-
Aug 13, 2026, 16:31Juan Manuel Cisneros Carrasco: The True Cost of Blood Donation
-
Aug 13, 2026, 16:25Connie Montgomery: Bridging the Gap Between Patients, Culture and Clinical Trials
-
Aug 13, 2026, 16:16Isabella Presch: A New AI Approach to Protein Engineering